An overview of the major CNS disorders -- Neurobiological correlates of CNS disorders -- Current pharmacological targets -- Premarketing efficacy evaluation -- Pharmacokinetic considerations : absorption, distribution, metabolism, and elimination -- Safety concerns relating to CNS drugs -- Preclinical and clinical safety evaluation -- CNS drug targets in development and future perspectives.